Select Medical Holdings Corporation (SEM) saw a significant drop in its stock price today, falling by 21.82% to $14.26. The company reported a revenue of $5.19 billion but experienced a slight revenue decline of 1.14%. Margins sit at 5%, lower than the industry average of 7.91%. The price-to-earnings (P/E) ratio stands at 8.59, below the industry average of 13.3, indicating potential undervaluation. However, the company's net debt to EBITDA ratio is high at 8.12 compared to the industry average of 11.65, signaling leverage concerns. Free cash flow has decreased by -12.75%, which may be contributing to investor apprehension.
Westlake Corporation (WLK) also faced a notable downturn, with its stock price dropping 13.46% to $79.85. With a market cap of $10.24 billion, Westlake operates within the Industrials sector, focusing on Major Chemicals. It has reported a revenue of $12.14 billion, reflecting a 9.22% annualized growth rate. Despite this, the company's margins are at 7%, below the industry average of 13.82%. Its P/E ratio is 16.99, higher than the industry average of 12.89, which may suggest overvaluation concerns among investors.
Cytokinetics Incorporated (CYTK) experienced a 12.98% decline in its stock price, now trading at $37.35. With a market capitalization of $4.42 billion, it operates in the Biotechnology sector, focusing on Pharmaceutical Preparations. Cytokinetics reported revenue of $18.47 million, which has fallen by -14.88%. The company is operating at a significant lostt. And with its free cash flow decreasing at an annualized rate of -52.92%, investor confidence seems shaken due to the company's financial health.
LeMaitre Vascular Inc. (LMAT) saw a 12.79% drop in its stock price, trading at $78.70. The company reported revenue of $219.86 million, with a healthy growth rate of 12.26%. The company's margins are robust at 24%, above the industry average of 12.94%, and it boasts a high gross margin of 69%. The P/E ratio is 40.15, significantly above the industry average of 35.71, which might be leading to concerns about overvaluation. However, the company’s free cash flow has grown by 11.97%, suggesting some underlying financial strength despite recent price action.
| Symbol | Name | Price | % Change | Market Cap |
|---|---|---|---|---|
| SEM | Select Medical Holdings Corporation - United States | $14.24 | -21.8 | $1.83 Billion |
| XYZ | Block Inc. Class A - United States | $46.55 | -20.4 | $28.62 Billion |
| WLK | Westlake Corporation - United States | $79.83 | -13.5 | $10.24 Billion |
| CYTK | Cytokinetics Incorporated - United States | $37.38 | -13 | $4.42 Billion |
| LMAT | LeMaitre Vascular Inc. - United States | $78.72 | -12.8 | $1.78 Billion |
